Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study.
Kian W, Zemel M, Kestenbaum EH, Rouvinov K, Alguayn W, Levitas D, Ievko A, Michlin R, Abod MA, Massalha I, Chernomordikov E, Sharb AA, Shalata W, Levison E, Roisman LC, Lavrenkov K, Peled N, Nesher L, Yakobson A.
Kian W, et al. Among authors: rouvinov k.
Medicine (Baltimore). 2022 Jan 14;101(2):e28561. doi: 10.1097/MD.0000000000028561.
Medicine (Baltimore). 2022.
PMID: 35029223
Free PMC article.